Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Borrows $8 Million in Two Deals

Premium

TORONTO--Tm Bioscience here has taken out two loans to fund growth. The company's DNA products are used in bioinformatics, functional genomics, biochips, and other applications.

Tm agreed to terms with MDS Capital that will provide it with a $4 million loan at 15 percent annual interest. Subject to approval of the Vancouver Stock Exchange, MDS will also receive 2 million bonus share purchase warrants that entitle it to acquire the shares at a price of 50 cents each for two years following issuance. Tm also borrowed $4 million from Canadian Medical Discoveries Fund with a similar warrant program attached. The fund already holds more than 11.6 million shares of Tm and warrants for another 7.6 million.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.